# Role of Pioglitazone in Preventing Diabetes

> **NCT00276497** · PHASE1 · COMPLETED · sponsor: **M.V. Hospital for Diabetes**

## Conditions studied

- Diabetes

## Interventions

- **DRUG:** Pioglitazone

## Key facts

- **NCT ID:** NCT00276497
- **Lead sponsor:** M.V. Hospital for Diabetes
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10
- **Primary completion:** —
- **Final completion:** 2008-05
- **Target enrollment:** — (—)
- **Last updated:** 2009-04-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00276497

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00276497, "Role of Pioglitazone in Preventing Diabetes". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00276497. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*